Mason Street Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-37,806
Closed -$2.45M 590
2020
Q4
$2.45M Sell
37,806
-81
-0.2% -$5.26K 0.04% 512
2020
Q3
$1.79M Sell
37,887
-703
-2% -$33.2K 0.03% 576
2020
Q2
$1.81M Buy
38,590
+683
+2% +$32.1K 0.04% 556
2020
Q1
$1.69M Hold
37,907
0.04% 505
2019
Q4
$2.21M Buy
37,907
+676
+2% +$39.4K 0.04% 539
2019
Q3
$2.24M Sell
37,231
-585
-2% -$35.1K 0.05% 499
2019
Q2
$2.11M Buy
37,816
+198
+0.5% +$11.1K 0.04% 532
2019
Q1
$2.1M Buy
37,618
+585
+2% +$32.6K 0.04% 550
2018
Q4
$1.67M Buy
37,033
+742
+2% +$33.5K 0.04% 566
2018
Q3
$2.39M Buy
36,291
+111
+0.3% +$7.31K 0.05% 454
2018
Q2
$2.33M Buy
36,180
+18,546
+105% +$1.19M 0.05% 465
2018
Q1
$976K Buy
17,634
+1,101
+7% +$60.9K 0.02% 846
2017
Q4
$791K Buy
16,533
+516
+3% +$24.7K 0.02% 905
2017
Q3
$809K Buy
16,017
+1,098
+7% +$55.5K 0.02% 889
2017
Q2
$813K Buy
14,919
+941
+7% +$51.3K 0.02% 872
2017
Q1
$589K Buy
13,978
+906
+7% +$38.2K 0.02% 936
2016
Q4
$561K Buy
13,072
+766
+6% +$32.9K 0.02% 938
2016
Q3
$508K Buy
12,306
+956
+8% +$39.5K 0.01% 931
2016
Q2
$453K Buy
11,350
+1,090
+11% +$43.5K 0.01% 933
2016
Q1
$346K Buy
10,260
+962
+10% +$32.4K 0.01% 972
2015
Q4
$315K Buy
9,298
+918
+11% +$31.1K 0.01% 969
2015
Q3
$250K Sell
8,380
-190
-2% -$5.67K 0.01% 1008
2015
Q2
$236K Buy
8,570
+372
+5% +$10.2K 0.01% 1031
2015
Q1
$207K Buy
8,198
+252
+3% +$6.36K 0.01% 1073
2014
Q4
$176K Buy
7,946
+284
+4% +$6.29K ﹤0.01% 1533
2014
Q3
$155K Buy
7,662
+352
+5% +$7.12K ﹤0.01% 1543
2014
Q2
$141K Buy
7,310
+242
+3% +$4.67K ﹤0.01% 1571
2014
Q1
$133K Sell
7,068
-2,062
-23% -$38.8K ﹤0.01% 1556
2013
Q4
$178K Buy
9,130
+1,754
+24% +$34.2K ﹤0.01% 1542
2013
Q3
$121K Buy
7,376
+526
+8% +$8.63K ﹤0.01% 1466
2013
Q2
$103K Buy
+6,850
New +$103K ﹤0.01% 1428